Company: DHR
Filing Date: 2025-03-26
Form Type: ARS
Source: 0000313616-25-000085
Chunk: 145

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: ARS
Chunk 145
---
 notes due 9/15/2025 ($500 million) (the “2025 U.S. Notes”)(f) 500 499 0.2% senior unsecured notes due 3/18/2026 (€1.3 billion) (the “2026 Biopharma Euronotes”)(b) 1,293 1,376 2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”)(f) 828 881 0.3% senior unsecured notes due 5/11/2027 (¥30.8 billion) (the “2027 Yen Notes”)(d) 195 218 1.2% senior unsecured notes due 6/30/2027 (€600 million) (the “2027 Euronotes”)(a) 620 660 0.45% senior unsecured notes due 3/18/2028 (€1.3 billion) (the “2028 Biopharma Euronotes”)(b) 1,291 1,374 1.125% senior unsecured bonds due 12/08/2028 (CHF 210 million) (the “2028 CHF Bonds”)(c) 233 252 2.6% senior unsecured notes due 11/15/2029 ($800 million) (the “2029 Biopharma Notes”)(b) 797 797 2.5% senior unsecured notes due 3/30/2030 (€800 million) (the “2030 Euronotes”)(f) 829 883 0.75% senior unsecured notes due 9/18/2031 (€1.8 billion) (the “2031 Biopharma Euronotes”)(b) 1,805 1,923 0.65% senior unsecured notes due 5/11/2032 (¥53.2 billion) (the “2032 Yen Notes”)(d) 337 376 1.35% senior unsecured notes due 9/18/2039 (€1.3 billion) (the “2039 Biopharma Euronotes”)(b) 1,282 1,365 3.25% senior unsecured notes due 11/15/2039 ($900 million) (